Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Consulting agrmnt
Appointed director
Notes underwriting agrmnt
Director departure
Bone Biologics Corp (BBLG) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/26/2016 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Stock Purchase Agreement with Musculoskeletal Transplant Foundation, Inc.",
"Stock Purchase Agreement with Orthofix, Inc.",
"Option Agreement for the Distribution and Supply of Sygnal™",
"Bone Biologics Corporation Convertible Secured Term Note issued to Hankey Capital on February 24, 2016",
"Bone Biologics Corporation Warrant issued to Hankey Capital on February 24, 2016",
"Registration Rights Agreement between the Company and Hankey Capital"
05/06/2015 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Bone Biologics, Corp. Convertible Secured Term Note issued to Hankey Capital, LLC on May 4, 2015",
"Bone Biologics, Corp. Warrant issued to Hankey Capital, LLC on May 4, 2015"
10/30/2014 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Bone Biologics, Corp. Convertible Secured Term Note issued to Hankey Capital, LLC on October 24, 2014",
"Bone Biologics, Corp. Warrant issued to Hankey Capital, LLC on October 24, 2014",
"Registration Rights Agreement by and between Bone Biologics, Corp. and Hankey Capital, LLC"
09/25/2014 8-K Entered into consulting agreement, Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Summary of Significant Accounting Policies",
"Summary of Significant Accounting Policies",
"Accrued Expenses",
"Accrued Expenses",
"Commitments and Contingencies",
"Commitments and Contingencies",
"Commitments and Contingencies",
"Commitments and Contingencies"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy